TOP TIERMARKET NEWSWIRE
News & sentiment

TARSUS PHARMACEUTICA (TARS) — News & AI sentiment

TARSUS PHARMACEUTICA (TARS) news roundup. 1 story in the last 24 hours, 5 in the past week, 9 over 30 days. Average 24-hour sentiment is 63/100 — bullish-leaning (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 5 sales totalling $4.3M — net selling of $4.3M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 63/100
7d stories
5
avg sentiment 53.8/100
30d stories
9
avg sentiment 49.1/100
Insider net (90d)
$4.3M
0 buys · 5 sells
Congress (90d)
0
0 buys · 0 sells

TARS news in the last 24 hours, 7 days, 30 days and 90 days

How much TARS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTARS storiesAvg AI sentimentRead
Last 24 hours163/100TARS headlines →
Last 7 days553.8/100TARS headlines →
Last 30 days949.1/100TARS headlines →
Last 90 days3454.7/100TARS headlines →

Latest stories on TARS

My 'Eye' Is On Tarsus Pharmaceuticals
Seeking Alpha63 · neutralanalyst
8h ago
3d ago
3d ago
4d ago
4d ago
Oct 13
Oct 13
Oct 13
Oct 6
Sep 29
Sep 24
Sep 16
Sep 10
Jefferies raises Tarsus Pharmaceuticals price target on guidance
Investing.com Analyst Ratings61 · neutralanalyst
Sep 8
Sep 8
Sep 4
Tarsus to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Sep 1
Sep 1
Aug 26
Aug 17
Tarsus (TARS) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Aug 13
Aug 6
Aug 6
Aug 6
Aug 6
Open TARS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →